BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tural C, Tor J, Sanvisens A, Pérez-Alvarez N, Martínez E, Ojanguren I, García-Samaniego J, Rockstroh J, Barluenga E, Muga R, Planas R, Sirera G, Rey-Joly C, Clotet B. Accuracy of simple biochemical tests in identifying liver fibrosis in patients co-infected with human immunodeficiency virus and hepatitis C virus. Clin Gastroenterol Hepatol 2009;7:339-45. [PMID: 19171202 DOI: 10.1016/j.cgh.2008.11.019] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 2.1] [Reference Citation Analysis]
Number Citing Articles
1 Chen Q, Li Q, Li D, Chen X, Liu Z, Hu G, Wang J, Ling W. Association between liver fibrosis scores and the risk of mortality among patients with coronary artery disease. Atherosclerosis 2020;299:45-52. [PMID: 32240838 DOI: 10.1016/j.atherosclerosis.2020.03.010] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 7.7] [Reference Citation Analysis]
2 Newsum AM, Kooij KW, Boyd A, Smit C, Wit FWNM, van der Meer JTM, Prins M, Reiss P, van der Valk M; MOSAIC study group, ATHENA observational HIV cohort and NVHB-SHM hepatitis working group. Progression of liver fibrosis following acute hepatitis C virus infection in HIV-positive MSM. AIDS 2019;33:833-44. [PMID: 30649050 DOI: 10.1097/QAD.0000000000002138] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
3 Navrotsky AN. [Diagnostic possibilities of methods for the evaluation of liver fibrosis in chronic viral hepatitis]. Ter Arkh 2016;88:149-55. [PMID: 28635835 DOI: 10.17116/terarkh20168811149-155] [Reference Citation Analysis]
4 Sherman KE, Sterling RK. HIV and the Liver. Zakim and Boyer's Hepatology 2018. [DOI: 10.1016/b978-0-323-37591-7.00037-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
5 Keating SM, Dodge JL, Norris PJ, Heitman J, Gange SJ, French AL, Glesby MJ, Edlin BR, Latham PS, Villacres MC, Greenblatt RM, Peters MG; Women’s Interagency HIV Study. The effect of HIV infection and HCV viremia on inflammatory mediators and hepatic injury-The Women's Interagency HIV Study. PLoS One 2017;12:e0181004. [PMID: 28902848 DOI: 10.1371/journal.pone.0181004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
6 Chromy D, Schwabl P, Bucsics T, Scheiner B, Strassl R, Mayer F, Aichelburg MC, Grabmeier-Pfistershammer K, Trauner M, Peck-Radosavljevic M, Reiberger T, Mandorfer M. Non-invasive liver fibrosis assessment and HCV treatment initiation within a systematic screening program in HIV/HCV coinfected patients. Wien Klin Wochenschr 2018;130:105-14. [PMID: 28744597 DOI: 10.1007/s00508-017-1231-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
7 López JJ, Pérez-Àlvarez N, Rodríguez RV, Jou A, Carbonell P, Jiménez JA, Soldevila L, Tenesa M, Tor J, Clotet B, Bechini J, Tural C. Optimal Use of Transient Elastography and Acoustic Radiation Force Impulse to Stage Liver Fibrosis in HIV/HCV-Coinfected Patients in Clinical Practice. J Ultrasound Med 2018;37:113-21. [PMID: 28715086 DOI: 10.1002/jum.14312] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
8 Kliemann DA, Wolff FH, Tovo CV, Alencastro PR, Ikeda ML, Brandão AB, Barcellos N, Fuchs SC. Biochemical non-invasive assessment of liver fibrosis cannot replace biopsy in HIV-HCV coinfected patients. Ann Hepatol 2016;15:27-32. [PMID: 26626637 DOI: 10.5604/16652681.1184197] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
9 Kim HN, Nance R, Van Rompaey S, Delaney JC, Crane HM, Cachay ER, Geng E, Boswell SL, Rodriguez B, Eron JJ, Saag M, Moore RD, Kitahata MM. Poorly Controlled HIV Infection: An Independent Risk Factor for Liver Fibrosis. JAIDS Journal of Acquired Immune Deficiency Syndromes 2016;72:437-43. [DOI: 10.1097/qai.0000000000000992] [Cited by in Crossref: 35] [Cited by in F6Publishing: 38] [Article Influence: 5.0] [Reference Citation Analysis]
10 Mandorfer M, Schwabl P, Steiner S, Reiberger T, Peck-Radosavljevic M. Advances in the management of HIV/HCV coinfection. Hepatol Int. 2016;10:424-435. [PMID: 26758592 DOI: 10.1007/s12072-015-9691-4] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 5.3] [Reference Citation Analysis]
11 Heaps-Woodruff JM, Wright PW, Ances BM, Clifford D, Paul RH. The impact of human immune deficiency virus and hepatitis C coinfection on white matter microstructural integrity. J Neurovirol 2016;22:389-99. [PMID: 26689572 DOI: 10.1007/s13365-015-0409-0] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
12 Crossan C, Tsochatzis EA, Longworth L, Gurusamy K, Davidson B, Rodríguez-Perálvarez M, Mantzoukis K, O’Brien J, Thalassinos E, Papastergiou V. Cost-effectiveness of non-invasive methods for assessment and monitoring of liver fibrosis and cirrhosis in patients with chronic liver disease: systematic review and economic evaluation. Health Technol Assess. 2015;19:1-409, v-vi. [PMID: 25633908 DOI: 10.3310/hta19090] [Cited by in Crossref: 96] [Cited by in F6Publishing: 106] [Article Influence: 12.0] [Reference Citation Analysis]
13 Chou CC, Tsai HC, Wu KS, Sy CL, Chen JK, Chen YS, Lee SS. Highly active antiretroviral therapy-related hepatotoxicity in human immunodeficiency virus and hepatitis C virus co-infected patients with advanced liver fibrosis in Taiwan. J Microbiol Immunol Infect 2016;49:546-53. [PMID: 25440980 DOI: 10.1016/j.jmii.2014.08.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
14 Alfaleh FZ, Alswat K, Helmy A, Al-hamoudi W, El-sharkawy M, Omar M, Shalaby A, Bedewi MA, Hadad Q, Ali SM, Alfaleh A, Abdo AA. The natural history and long-term outcomes in patients with chronic hepatitis C genotype 4 after interferon-based therapy. Liver Int 2013;33:871-83. [PMID: 23490034 DOI: 10.1111/liv.12127] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
15 Abd El Rihim AY, Omar RF, Fathalah W, El Attar I, Hafez HA, Ibrahim W. Role of fibroscan and APRI in detection of liver fibrosis: a systematic review and meta-analysis. Arab J Gastroenterol. 2013;14:44-50. [PMID: 23820499 DOI: 10.1016/j.ajg.2013.05.002] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 2.9] [Reference Citation Analysis]
16 Alghamdi AS, Sanai FM, Ismail M, Alghamdi H, Alswat K, Alqutub A, Altraif I, Shah H, Alfaleh FZ; Saudi Association for the Study of Liver Diseases and Transplantation. SASLT practice guidelines: management of hepatitis C virus infection. Saudi J Gastroenterol 2012;18 Suppl:S1-32. [PMID: 23006491 DOI: 10.4103/1319-3767.101155] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
17 Muhi A, Ichikawa T, Motosugi U, Sano K, Fatima Z, Matsuda M, Fujii H, Enomoto N, Araki T. Diffusion-weighted imaging of hepatocellular carcinoma for predicting early recurrence and survival after hepatectomy. Hepatol Int 2013;7:662-8. [PMID: 26201799 DOI: 10.1007/s12072-012-9383-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
18 Bambha K, Pierce C, Cox C, French AL, Tien PC, Sharp GB, Augenbraun M, Glesby MJ, Villacres MC, Plankey M, Strickler HD, Gange SJ, Peters MG. Assessing mortality in women with hepatitis C virus and HIV using indirect markers of fibrosis. AIDS 2012;26:599-607. [PMID: 22156972 DOI: 10.1097/QAD.0b013e32834fa121] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 3.8] [Reference Citation Analysis]
19 Mehta SH, Buckle GC. Assessment of liver disease (noninvasive methods). Curr Opin HIV AIDS 2011;6:465-71. [PMID: 21857222 DOI: 10.1097/COH.0b013e32834b55c7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
20 Pineda JA, Neukam K, Mallolas J, López-cortés LF, Cartón JA, Domingo P, Moreno S, Iribarren JA, Clotet B, Crespo M, de Los Santos I, Ortega E, Knobel H, Jiménez-expósito MJ, Macías J. Hepatic safety of efavirenz in HIV/hepatitis C virus-coinfected patients with advanced liver fibrosis. Journal of Infection 2012;64:204-11. [DOI: 10.1016/j.jinf.2011.10.016] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
21 Smith JO, Sterling RK. Noninvasive Markers of Liver Injury and Fibrosis. HIV and Liver Disease 2012. [DOI: 10.1007/978-1-4419-1712-6_5] [Reference Citation Analysis]
22 Crespo G, Martinez SM, Forns X. Assessing the Progression of Chronic HCV to Cirrhosis. Chronic Hepatitis C Virus 2012. [DOI: 10.1007/978-1-4614-1192-5_3] [Reference Citation Analysis]
23 Tor J, Muga R. [Evaluation of liver fibrosis by non-invasive methods]. Med Clin (Barc) 2011;137:642-4. [PMID: 21752404 DOI: 10.1016/j.medcli.2011.05.002] [Reference Citation Analysis]
24 Resino S, Asensio C, Bellón JM, Carmona R, Miralles P, López JC, Cosín J, Álvarez E, Berenguer J. Diagnostic accuracy of the APRI, FIB-4, and the Forns index for predicting liver fibrosis in HIV/HCV-coinfected patients: a validation study. J Infect. 2011;63:402-405. [PMID: 21839774 DOI: 10.1016/j.jinf.2011.07.017] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
25 Bruno R, Sacchi P, Cima S, Maiocchi L, Patruno SF, Klersy C, Barbarini G, Zuccaro V, Camma C, Filice G. Correlation between FIB4, liver stiffness and metabolic parameters in patients with HIV and hepatitis C virus co-infection. Dig Liver Dis 2011;43:575-8. [PMID: 21596630 DOI: 10.1016/j.dld.2011.03.009] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
26 Mendeni M, Foca E, Gotti D, Ladisa N, Angarano G, Albini L, Castelnuovo F, Carosi G, Quiros-roldan E, Torti C. Evaluation of Liver Fibrosis: Concordance Analysis between Noninvasive Scores (APRI and FIB-4) Evolution and Predictors in a Cohort of HIV-Infected Patients without Hepatitis C and B Infection. Clinical Infectious Diseases 2011;52:1164-73. [DOI: 10.1093/cid/cir071] [Cited by in Crossref: 57] [Cited by in F6Publishing: 62] [Article Influence: 4.8] [Reference Citation Analysis]
27 Lin ZH, Xin YN, Dong QJ, Wang Q, Jiang XJ, Zhan SH, Sun Y, Xuan SY. Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis. Hepatology 2011;53:726-36. [PMID: 21319189 DOI: 10.1002/hep.24105] [Cited by in Crossref: 663] [Cited by in F6Publishing: 692] [Article Influence: 55.3] [Reference Citation Analysis]
28 Ena J, Ruiz-de-apodaca RF, Pasquau F, Amador C, Benito C. Cross-sectional epidemiology of hepatitis C virus detection and treatment in HIV-infected patients. European Journal of Internal Medicine 2011;22:66-72. [DOI: 10.1016/j.ejim.2010.08.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
29 Resino S, Bellón JM, Asensio C, Micheloud D, Miralles P, Vargas A, Catalán P, López JC, Alvarez E, Cosin J. Can serum hyaluronic acid replace simple non-invasive indexes to predict liver fibrosis in HIV/Hepatitis C coinfected patients? BMC Infect Dis. 2010;10:244. [PMID: 20723207 DOI: 10.1186/1471-2334-10-244] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 1.2] [Reference Citation Analysis]
30 Calès P, Halfon P, Batisse D, Carrat F, Perré P, Penaranda G, Guyader D, d'Alteroche L, Fouchard-Hubert I, Michelet C, Veillon P, Lambert J, Weiss L, Salmon D, Cacoub P. Comparison of liver fibrosis blood tests developed for HCV with new specific tests in HIV/HCV co-infection. J Hepatol 2010;53:238-44. [PMID: 20493576 DOI: 10.1016/j.jhep.2010.03.007] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 2.5] [Reference Citation Analysis]
31 Berenguer J. [Hepatitis C virus infection in HIV coinfected patients]. Rev Clin Esp 2010;210:338-41. [PMID: 20609839 DOI: 10.1016/j.rce.2010.04.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
32 Macías J, González J, Ortega E, Tural C, Cabrero E, Burgos A, Pineda JA; GRAFIHCO Study Team. Use of simple noninvasive biomarkers to predict liver fibrosis in HIV/HCV coinfection in routine clinical practice. HIV Med 2010;11:439-47. [PMID: 20180868 DOI: 10.1111/j.1468-1293.2009.00812.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 0.1] [Reference Citation Analysis]